Heat Biologics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
341.60
1,519.90
5,793.80
Cost of Goods Sold (COGS) incl. D&A
1,397.20
66.90
116.00
-
-
-
Gross Income
1,397.20
66.90
116.00
-
-
-
SG&A Expense
5,167.50
12,120.00
20,906.00
13,336.90
14,504.40
23,020.90
EBIT
6,564.60
12,186.90
21,022.00
13,127.30
13,118.60
17,464.40
Unusual Expense
30.40
7.30
-
-
224.30
495.90
Non Operating Income/Expense
54.30
16.20
198.00
670.80
101.30
117.80
Interest Expense
79.10
73.40
364.00
549.40
-
-
Pretax Income
6,609.90
12,243.20
21,122.00
12,974.80
13,219.40
17,576.80
Income Tax
-
-
-
-
809.50
985.50
Consolidated Net Income
8,909.90
12,243.20
21,122.00
12,974.80
12,409.90
16,591.30
Net Income
8,711.30
11,788.80
20,295.00
12,574.00
11,841.70
15,733.90
Net Income After Extraordinaries
8,711.30
11,788.80
20,295.00
12,574.00
11,841.70
15,733.90
Net Income Available to Common
9,073.00
11,788.80
20,295.00
12,574.00
11,841.70
15,733.90
EPS (Basic)
24.20
18.30
25.30
7.10
3.08
0.90
Basic Shares Outstanding
374.70
645.50
801.60
1,758.60
3,845.30
17,485.50
EPS (Diluted)
24.21
18.26
25.32
7.15
3.08
0.90
Diluted Shares Outstanding
374.70
645.50
801.60
1,758.60
3,845.30
17,485.50
EBITDA
6,558.30
12,120.00
20,906.00
12,995.20
12,984.50
17,227.10
Non-Operating Interest Income
10.10
40.60
66.00
31.10
22.20
265.80
Minority Interest Expense
198.50
454.40
827.00
400.80
568.20
857.40
Other After Tax Income (Expense)
2,300.00
-
-
-
-
-
Preferred Dividends
361.70
-
-
-
-
-
About Heat Biologics
View Profile
